Latest Opioid Stories
First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. RICHMOND, Va., July 10, 2014 /PRNewswire/ -- Kaleo, a privately-held
LONDON, July 9, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
All the features that make PainEDU the leading pain education website are still available, but now with an enhanced design. Newton, MA (PRWEB) July 08, 2014
- Pre-NDA meeting scheduled with FDA in July DUBLIN and RALEIGH, N.C., July 7, 2014 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo
Physical Therapy: The Key to Reducing the Risks Connected with Painkiller Use and Abuse Astoria, NY (PRWEB) July 04, 2014 Physical therapy shown to increase
The results of a new study demonstrate that starting hospitalized patients who have an opioid (heroin) addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment program can greatly reduce whether they relapse after they are discharged.
Empowering healthcare providers to treat pain more safely and effectively. Newton, MA (PRWEB) June 30, 2014 Inflexxion, Inc., a behavioral health technology
In an article published by JAMA Internal Medicine, LTC Wayne B. Jonas, MD, USA (Ret.), President and CEO of Samueli Institute, and LTG Eric B.
The Makers of Topricin® Natural Pain Relief & Healing products invite their customers and community to join them in mission to help those in need who suffer with pain and addiction.
SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published
- Emitting flashes of light; glittering.